Cargando…
Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
Autores principales: | Bhattacharyya, M, Todi, SK, Majumdar, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095185/ http://dx.doi.org/10.1186/cc5291 |
Ejemplares similares
-
Comparison of Glycemic Control between Continuous Regular Insulin Infusion and Single-dose Subcutaneous Insulin Glargine Injection in Medical Critically Ill Patients
por: Bhurayanontachai, Rungsun, et al.
Publicado: (2018) -
Intensive insulin therapy versus glycemic control in critically ill patients: a prospective controlled trial
por: Azevedo, JR, et al.
Publicado: (2007) -
Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009) -
Impact of cumulative calorie and protein deficits in critically ill patients
por: Dey, R, et al.
Publicado: (2011) -
Endogenous insulin secretion and suppression during and after sepsis in critically ill patients: implications for tight glycemic control protocols
por: Pretty, CG, et al.
Publicado: (2011)